Bioavailability: Why Delivery Matters More Than Dose

Co-authored by Stefanie Morgan, PhD. VP of Research and Applied Sciences, AgelessRx.

You buy a supplement labeled 500 mg. You assume 500 mg enters your body. This assumption is wrong. For most supplement ingredients, you absorb a fraction of the label dose. Protocol 01 addresses this with five bioavailability strategies that increase the active dose reaching your cells. What you absorb matters far more than what you swallow.

The Bioavailability Problem: Why Most Supplements Fail

Here is how the supplement industry wants you to think about pills: you buy a product. The label says 500 mg of ingredient X. You take it. 500 mg enters your body. Your cells use 500 mg. Problem solved.

This is fantasy.

In reality, most supplement ingredients have poor bioavailability. The path from your mouth to your cells runs through several barriers that degrade or eliminate the compound along the way.

First, the compound meets stomach acid. Some compounds break down immediately. Others survive but are damaged. Second, your intestinal lining has to absorb the compound, and this is a selective process. Many compounds cannot cross that barrier efficiently. Third, the compound that does get through enters your bloodstream, where your liver often captures it and metabolizes it into inactive forms before it reaches your tissues. This step is called first-pass metabolism, and it removes a large share of many compounds.

By the time the compound reaches your cells, the active dose is often a small fraction of what the label promised.

Curcumin is the textbook case. Taken on its own, very little of an oral dose reaches the bloodstream, often under 1 percent. Most of it is metabolized or excreted before it can act. You paid for the label dose. You absorbed a sliver. This is typical, not unusual.

For most longevity supplements on the market, this is the failure the industry does not advertise. You pay for doses you never actually receive. Many companies know this and do nothing about it. They use cheap ingredient forms and hope buyers do not ask.

Protocol 01 takes the opposite approach. Instead of printing high label doses of poorly absorbed compounds, we engineer for absorption. We use delivery systems and ingredient forms that increase what actually reaches your cells.

The Five Bioavailability Strategies in Protocol 01

1. Liposomal Delivery: EGCG, Fisetin and Curcumin

Some of the most useful compounds in Protocol 01 are hydrophobic, meaning they repel water. Your intestinal tract is lined with water-based mucus. A water-fearing compound trying to cross a water-based barrier struggles to get through.

Liposomal delivery solves this. A liposome is a microscopic sphere built from lipid (fat). Its outer surface is water-loving, so it interacts with your intestinal environment. Its interior is water-fearing, creating a protected pocket.

You encapsulate a water-fearing compound inside the liposome. The compound is now shielded from the aqueous environment. The liposome crosses the intestinal barrier intact, your intestinal cells absorb it as a fat-soluble particle, and once inside, the liposome releases its cargo so the active compound can reach your cellular machinery.

In Protocol 01, liposomal delivery is used for:

• EGCG (epigallocatechin gallate, the active compound from green tea): 80 mg in liposomal form
• Fisetin (a senolytic compound taken monthly): 300 mg in liposomal form
• Curcumin: 150 mg, in liposomal form

These are compounds where standard absorption is poor and inconsistent. Liposomal encapsulation improves both how much is absorbed and how reliably.

2. Enhanced Molecular Forms: Active, Pre-Converted Compounds

Some compounds cannot be used by your body directly. Your liver has to convert them into an active form first. When that conversion is inefficient, you lose bioavailability. The solution is to skip the conversion and use the active form from the start.

Protocol 01 uses this strategy in three places.

Dihydroberberine instead of berberine. Standard berberine, studied for glucose metabolism, has to be converted by your body into dihydroberberine before it can work. Dihydroberberine reaches roughly 5 times the blood levels of standard berberine in a human crossover pilot. Protocol 01 includes 100 mg of dihydroberberine directly, so you get the active form without the conversion bottleneck.

5-MTHF instead of folic acid. Standard supplemental folate is folic acid, a synthetic form your body must convert to 5-methyltetrahydrofolate (5-MTHF), the active form. That conversion depends on the MTHFR enzyme, and many people carry common genetic variants that slow it. Roughly 30 to 50 percent of people carry at least one MTHFR variant, and for them, folic acid may not deliver usable folate. Protocol 01 uses 5-MTHF directly, already in the active form, so your cells can use it regardless of your MTHFR genetics.

Methylcobalamin instead of cyanocobalamin. Standard supplemental B12 is cyanocobalamin, a synthetic form your body has to convert to the active form. Protocol 01 uses methylcobalamin directly, pre-converted and immediately usable, so you are not relying on conversion efficiency.

3. Enzyme Co-Administration: Glucoraphanin With Myrosinase

Some compounds require enzymatic conversion in your digestive tract rather than your liver. If the enzyme is missing, conversion fails. Most supplements ignore this.

Sulforaphane is the clearest example. You do not consume sulforaphane directly. Broccoli contains glucoraphanin, a precursor, and an enzyme called myrosinase that converts glucoraphanin into sulforaphane in your gut. Fresh raw broccoli contains active myrosinase, so conversion is efficient. Dried or processed glucoraphanin powder usually has the enzyme deactivated or absent, and without it, conversion drops sharply. You lose most of the compound's potential.

Most supplement companies skip this. They include glucoraphanin and hope for the best, or they leave it out entirely.

Protocol 01 includes:

• Glucoraphanin: 70 mg
• Myrosinase enzyme: 50 mg
• Sodium ascorbate: 65 mg

The entire Protect pill uses a delayed-release capsule designed to survive stomach acid and release in the small intestine. This protects all Protect ingredients from gastric degradation, and it is especially important for myrosinase: the enzyme meets glucoraphanin right where absorption occurs. The three compounds meet in your gut. The enzyme works on the precursor, Vitamin C acts as a cofactor, and sulforaphane is produced at higher efficiency.

The result: conversion closer to 40 percent instead of roughly 10 percent, a threefold to fourfold improvement in active compound delivered to your cells.

4. Absorption Enhancers: Piperine With Curcumin

Some compounds are not just poorly absorbed, they are actively metabolized away. Curcumin is the classic example: poor intestinal absorption combined with rapid breakdown. You lose it on the way in and on the way through.

In 1998, a research team led by Shoba published a landmark finding in Planta Medica. In healthy volunteers, 2 g of curcumin taken alone produced serum levels that were undetectable or very low. When the same curcumin was combined with 20 mg of piperine (the compound that makes black pepper hot), curcumin bioavailability increased by approximately 2000 percent.

The mechanism: piperine inhibits the intestinal and hepatic glucuronidation that normally breaks curcumin down and clears it from the body. By slowing that breakdown, piperine allows more curcumin to stay in circulation and reach tissues.

Protocol 01 includes:

• Curcumin: 150 mg, in liposomal form (strategy 1)
• Piperine: 5 mg

Curcumin is the one ingredient that gets two strategies stacked together. Liposomal encapsulation does the primary absorption work: in published pharmacokinetic studies, liposomal curcumin absorbs roughly 5 to 20 times better than standard curcumin, with human reviews landing around 5 to 10 times. Piperine is added as a complementary enhancer that slows how quickly curcumin is cleared, so more of it stays in circulation. The 5 mg of piperine is small and is not dosed for its own effects; it supports curcumin retention. To be precise: the Shoba result used 20 mg of piperine, so the 5 mg in Protocol 01 is a supporting enhancer alongside liposomal delivery, not a standalone reproduction of that study.

5. Chelated Minerals: Magnesium Bisglycinate

Mineral absorption is a special case. Most mineral supplements use simple salt forms: magnesium oxide, magnesium citrate, zinc sulfate, and so on. These forms are cheap, but they absorb poorly and often cause GI side effects like bloating, cramping, and loose stools.

Chelated minerals are different. The mineral is bound to an amino acid, creating a complex that your intestines recognize and absorb more efficiently. The amino acid co-absorbed with the mineral can also provide its own benefits.

Protocol 01 includes 200 mg of magnesium bisglycinate. Magnesium is bound to glycine, a simple amino acid. Glycine itself has been studied for sleep quality and stress resilience. You get improved mineral absorption alongside glycine's effects.

Additional Form Optimizations

Beyond the five strategies above, Protocol 01 selects specific molecular forms of several ingredients based on their absorption profiles. These are deliberate formulation choices.

Pterostilbene instead of resveratrol.

Resveratrol is the best-known polyphenol in longevity science, but it has a well-documented absorption problem: rapid metabolism and low oral uptake leave little in systemic circulation. Pterostilbene is a methylated analog with better pharmacokinetics. Two methyl groups in place of hydroxyl groups increase lipophilicity and metabolic stability, giving roughly 4 times the oral bioavailability of resveratrol. Protocol 01 includes 50 mg of pterostilbene because it delivers meaningful systemic exposure where resveratrol, at practical doses, does not.

Isoquercetin instead of quercetin.

Quercetin is widely used in longevity formulas, especially in senolytic research. Standard quercetin has poor water solubility and erratic absorption. Isoquercetin is a glycoside form: an added glucose molecule improves water solubility and intestinal absorption, and published pharmacokinetic data show it reaches higher plasma quercetin levels than equivalent doses of standard quercetin. Protocol 01 uses 150 mg of isoquercetin in the monthly senolytic pulse for this reason.

Spermidine trihydrochloride.

Spermidine is a naturally occurring polyamine studied for its role in autophagy. The trihydrochloride salt was selected for stability and consistent absorption compared with plant-derived spermidine extracts, which vary widely in actual spermidine content. The salt form delivers a precise, reproducible 10 mg dose.

Fenugreek galactomannan for senolytic absorption.

The monthly senolytic pulse includes 150 mg of fenugreek galactomannan, a soluble fiber that acts as an absorption enhancer for fisetin. Fisetin, like many flavonoids, has poor solubility and limited intestinal absorption. Fenugreek galactomannan improves its dissolution in the gut and increases the fraction that crosses the intestinal lining. This is a targeted strategy specific to the monthly senolytic protocol.

Dose Context: Why Multi-Pathway Design Requires Tradeoffs

In any multi-pathway protocol, dosing involves deliberate tradeoffs between pathway breadth, capsule count, and per-ingredient dose. Research studies usually isolate a single compound at a high dose. A systems-level protocol allocates capsule space across many compounds targeting different mechanisms. Understanding this distinction matters for evaluating any longevity formula.

Protocol 01 prioritizes multi-hallmark coverage within a six-capsule daily footprint. For most ingredients, doses match or closely approach published research ranges. For a few, the dose reflects a deliberate choice: lower per-ingredient volume in exchange for broader coverage and enhanced bioavailability.

Two examples:

• EGCG: 80 mg in liposomal form. Studies on standard EGCG powder often use 200 to 800 mg daily. Liposomal delivery increases absorption efficiency, which narrows the gap between the label dose and what reaches your cells.
• Pterostilbene: 50 mg. Some protocols use 250 mg or more of resveratrol daily. Pterostilbene was chosen over resveratrol because its methylated structure delivers roughly 4 times the bioavailability, so a lower label dose translates to a more competitive effective dose.

The principle: every claim is substantiated at the actual delivered dose, not extrapolated from higher-dose studies. Transparency about dosing context is part of the protocol's design philosophy.

Why Competitors Miss This

Most supplement competitors use standard ingredient forms and standard dosing. They do not engineer for absorption. Why?

• Cost. Liposomal EGCG is significantly more expensive than standard EGCG powder.
• Cost. Dihydroberberine costs more than berberine.
• Complexity. Delayed-release capsules that protect acid-sensitive ingredients add manufacturing cost and difficulty. Protocol 01 houses all Protect ingredients in a delayed-release capsule, shielding compounds like glucoraphanin, myrosinase, curcumin, and spermidine from gastric degradation. Most competitors skip this step.
• Cost. Using 5-MTHF instead of folic acid increases ingredient costs.
• Industry inertia. Many supplement companies have used the same cheap forms for decades.

In a margin-squeezed industry, the default is to minimize cost: use the cheapest forms, add a large label dose, and hope buyers do not ask whether they are absorbing anything. That is the commodity-supplement model. Protocol 01 took the opposite approach. Better forms, better delivery, better absorption.

Frequently Asked Questions

Does bioavailability really matter if the dose is right?

More than the dose does. Absorb 10 percent of a compound and the label number is fiction, because 90 percent never reaches you. Our liposomal, piperine-paired curcumin is active at a practical dose. The same amount of plain curcumin powder is mostly lost to metabolism. What you absorb is the only number that counts. 

Why doesn't every supplement use these strategies?

Because it costs more and takes more work. Liposomal delivery is expensive. Dihydroberberine costs more than berberine. Co-delivering myrosinase needs specialized capsules. Active 5-MTHF costs more than folic acid. Most brands take the cheap path and hope you do not ask. We built for what reaches your cells. That is the whole difference. 

How do you set your doses?

We dose for what reaches your cells, not for a bigger number on the label. Take EGCG. On its own it is barely absorbed, often under a couple of percent of what you swallow. The liposomal form protects it through the gut and roughly doubles what reaches your blood, so 80 mg does the work of a noticeably larger standard dose. Pterostilbene at 50 mg delivers the systemic exposure of far more resveratrol, because it is roughly four times as bioavailable. The label numbers are smaller by design. The amount your body actually uses is not. 

How do I know the bioavailability claims are real?

Because every one is published. Dihydroberberine versus berberine has human pharmacokinetic data. Shoba 1998 is the reference for piperine and curcumin. The myrosinase mechanism is established biochemistry. Liposomal delivery is validated technology. We cite all of it, and the full reference list is yours on request. 

Wouldn't it be better to just use higher doses instead of optimizing bioavailability?

No. A bigger dose of a poorly absorbed compound is still poorly absorbed. Double the curcumin powder and you mostly double what you excrete. More material on the label is not more benefit in your body. We deliver a dose your cells can use, in six capsules you will actually take every day. That beats a bigger number that passes straight through. 

Can I achieve the same results by buying individual supplements at higher doses?

You could try. It means sourcing fifteen to twenty separate products, getting every form right, pairing myrosinase with glucoraphanin and piperine with curcumin, and timing the delayed-release yourself. Get any one wrong and the absorption advantage disappears. And you still would not have all Protect ingredients co-delivered in one delayed-release capsule. Protocol 01 is that engineering, already done.

Key Takeaways

• Most supplement ingredients have poor bioavailability. You absorb a fraction of the label dose.
• Curcumin taken alone is very poorly absorbed; most of an oral dose is metabolized before it reaches the bloodstream.
• Protocol 01 uses five bioavailability strategies: liposomal delivery, active pre-converted forms, enzyme co-administration, absorption enhancers, and chelated minerals.
• Examples of improvement: dihydroberberine reaches higher blood levels than standard berberine at a lower dose; piperine raised curcumin bioavailability about 2000 percent in the Shoba 1998 human study; co-delivered myrosinase can roughly triple to quadruple sulforaphane yield from glucoraphanin.
• Some ingredients are dosed below research maximums. We claim only what we can substantiate at our actual doses.
• What you absorb matters far more than what you swallow. Engineering delivery is the difference between a supplement that works and one that does not.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement protocol.

About the Author

Dr. Stefanie Morgan is VP of Research and Applied Sciences at AgelessRx, where she leads the company's clinical research program. A Stanford-trained scientist, she co-authored the PEARL trial, one of the largest randomized, placebo-controlled studies of rapamycin for human healthspan, and leads AgelessRx's research on rapamycin bioavailability and blood-level dynamics. Her work focuses on translating research doses into real-world cellular exposure.